Genetic Engineering & Biotechnology News（基因工程与生物工程与生物技术新闻杂志）影响因子_期刊投稿发表

期刊简介

Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success.GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.

遗传工程与生物技术新闻（GEN）是玛丽·安·利伯特公司的旗舰出版物。《GEN》于1980年出版，是该领域的第一份出版物，至今仍是该行业爆炸式增长的关键驱动力，为新技术和应用的开发、投资增长和职业机会铺平了道路。GEN拥有近40年的出版经验，在推动出版业的生产力和发展方面发挥着关键作用。通过其基石杂志、高频通讯和动态多媒体资源套件，GEN保持了无与伦比的诚信、影响力和专业知识。GEN是研究人员和管理人员所依赖的360度资源，这些信息对其组织的成功至关重要。GEN'的编辑覆盖面之广在行业中无人能及，独家报道了生物制品的整个生命周期，涵盖五大关键支柱：药物发现、生物加工、OMICS、转化医学和基因编辑。

《Genetic Engineering & Biotechnology News》期刊已被查看：次

分区信息